NHS National Pharmaceuticals Transition 2022_1

Concepts

• pharmaceutical products
• nhs national pharmaceuticals
• runcorn
• potential periods of call-offs
• nhs national pharmaceuticals transition
• transition
• period of framework agreement
• offer reference number
• discretion of the authority
• maximum contract length

Location

Description

Invitation to offer for NHS National Pharmaceuticals Transition 2022_1 Offer reference number: CM/PHG/21/5637 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement: Transition: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months) Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months) Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months)

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 03 - Framework Agreement and Terms and Conditions https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2f/_J5KU.TO3C0... Document No. 05a(i) Product Listing and usage Transition CM_PHG_21_5637_00 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2p/Eng2.ORgPz.... Document No. 04 - Contract technical specification https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2G/_4YZMvnFYqE... Document No. 05a(v) Product Listing and Usage Hospital only Products CM_PHG_21_5637_02 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2k/QyHWHOmm3s7... Document No. 05b - Selectt offer schedule instructions https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2o/HndL4pvBUmO... Document No. 05a (ii), 05a (iv), 05a (vi) CM_PHG_17_5532 SELECTT Application https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2j/A9.eKbRY5Jw... Document No. 00 - Read Me First Document https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2n/so017jhuxyw... Document No. 05a(iii) Product Listing and usage Oral Products plus non-parenterals CM_PHG_21_5637_01 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2s/nD3VJF8W.kK... Document No. 01 - Invitation to offer covering letter https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2e/y87p3nOERZS... Document No. 07a - Quality control technical sheet https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb26/yvqgp3.WSAY... Document No. 09 - Stability Data Requirments https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2F/cOg8CjvacGG... Document No. 02 - Terms of offer https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2i/Vjj5x_19ZWu... Document No. 08 - Confidential information schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2d/hClzb_TqTbd... Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2E/pJ5gOOJGSel... Document No. 06 - Form of offer https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb24/evB8b8Gkut9... Qualification Questionnaire - Transition 2022_1 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb25/ebTSPjhvObm...